NCT01549145

Brief Summary

The objectives of this study are to evaluate the safety and efficacy of applying electrical stimulation on the promontorium (EPS) for the suppression of tinnitus in a sub-chronic stimulation regimen.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2010

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2010

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2011

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

March 6, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 9, 2012

Completed
Last Updated

August 29, 2012

Status Verified

August 1, 2012

Enrollment Period

10 months

First QC Date

March 6, 2012

Last Update Submit

August 28, 2012

Conditions

Keywords

SevereOngoingUnilateralpresent for more than 6 months

Outcome Measures

Primary Outcomes (1)

  • Efficacy

    Study efficacy evaluations will be based on the analysis of pre and post procedure tinnitus severity characteristics (THI, MML, Pitch matching and VAS values).

    2 months

Secondary Outcomes (1)

  • Safety

    2 months

Study Arms (1)

NIMBUS multifunctional stimulator

EXPERIMENTAL

A Multifunctional Stimulator (Nimbus by Newmedic, Hemodia) for clinical use. The stimulator is also dedicated for Electrical Promontory Stimulation (EPS)

Device: Nimbus Multifunctional Stimulator

Interventions

A Multifunctional Stimulator (Nimbus by Newmedic, Hemodia) for clinical use. The stimulator is also dedicated for Electrical Promontory Stimulation (EPS)

NIMBUS multifunctional stimulator

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Total score on the Handicap Inventory (THI) of at least 40.
  • Visual scale over 5.
  • Tinnitus origin is peripheral (related to long term noise exposure, or to a sudden exposure to a very loud noise etc.)
  • Tinnitus is on-going; present for more than 50% of the time over the past 12 months.
  • Unilateral tinnitus
  • Tinnitus prevalent at least 12 months.
  • Willingness to abstain from part taking in other, non-study procedures indicated to lessen tinnitus and/or its perception.
  • Willing and able to refrain from engaging in activities or work involving loud noise exposure.
  • Male or females 18-60 years of age

You may not qualify if:

  • Prior history of sudden hearing loss and/or fluctuating hearing levels.
  • Tinnitus prevalent more than 3 years.
  • History of frequent middle ear infections
  • Patient under immunosuppressant therapy
  • Auditory nerve damage.
  • Vestibular Schwannoma
  • Cochlear implant.
  • Pregnant or lactating.
  • Developmental disability or cognitive impairment that would make it difficult for the subject to partake in the clinical study, including adequate comprehension of the informed consent form and ability to record the necessary measurements.
  • Involvement in litigation and/or a worker's compensation claim and/or receiving disability benefits related to tinnitus and/or hearing loss.
  • Not being physically or geographically capable of returning for scheduled follow-up visits.
  • Any physical, psychological, or emotional disorder that would interfere with the planned surgical operations
  • Mentally retarded, developmentally delayed or suffering from organic brain dysfunction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shaare Zedek Medical Center

Jerusalem, Israel

Location

MeSH Terms

Conditions

TinnitusLymphoma, Follicular

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsLymphoma, Non-HodgkinLymphomaNeoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2012

First Posted

March 9, 2012

Study Start

June 1, 2010

Primary Completion

April 1, 2011

Study Completion

April 1, 2011

Last Updated

August 29, 2012

Record last verified: 2012-08

Locations